KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Shares Outstanding (Weighted Average) (2016 - 2025)

Petmed Express' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $20.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.21% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $20.9 million, up 1.21%, while the annual FY2025 figure was $20.6 million, 0.98% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $20.9 million in Q4 2025 per PETS's latest filing, roughly flat from $20.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.9 million in Q4 2025 to a low of $20.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $20.4 million, with a median of $20.3 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.09% in 2021, then rose 1.3% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $20.2 million in 2021, then rose by 0.46% to $20.3 million in 2022, then grew by 0.39% to $20.4 million in 2023, then increased by 1.25% to $20.6 million in 2024, then grew by 1.21% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Shares Outstanding (Weighted Average) are $20.9 million (Q4 2025), $20.8 million (Q3 2025), and $20.8 million (Q2 2025).